These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29541943)

  • 1. Differential Effects of Strategies to Improve the Transduction Efficiency of Lentiviral Vector that Conveys an Anti-HIV Protein, Nullbasic, in Human T Cells.
    Rustanti L; Jin H; Li D; Lor M; Sivakumaran H; Harrich D
    Virol Sin; 2018 Apr; 33(2):142-152. PubMed ID: 29541943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A HIV-1 Tat mutant protein disrupts HIV-1 Rev function by targeting the DEAD-box RNA helicase DDX1.
    Lin MH; Sivakumaran H; Jones A; Li D; Harper C; Wei T; Jin H; Rustanti L; Meunier FA; Spann K; Harrich D
    Retrovirology; 2014 Dec; 11():121. PubMed ID: 25496916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mutant Tat protein inhibits infection of human cells by strains from diverse HIV-1 subtypes.
    Rustanti L; Jin H; Lor M; Lin MH; Rawle DJ; Harrich D
    Virol J; 2017 Mar; 14(1):52. PubMed ID: 28288662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mutant Tat protein provides strong protection from HIV-1 infection in human CD4+ T cells.
    Apolloni A; Lin MH; Sivakumaran H; Li D; Kershaw MH; Harrich D
    Hum Gene Ther; 2013 Mar; 24(3):270-82. PubMed ID: 23298160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shutdown of HIV-1 Transcription in T Cells by Nullbasic, a Mutant Tat Protein.
    Jin H; Li D; Sivakumaran H; Lor M; Rustanti L; Cloonan N; Wani S; Harrich D
    mBio; 2016 Jul; 7(4):. PubMed ID: 27381288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strong
    Jin H; Sun Y; Li D; Lin MH; Lor M; Rustanti L; Harrich D
    mBio; 2019 Aug; 10(4):. PubMed ID: 31455650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mutant tat protein inhibits HIV-1 reverse transcription by targeting the reverse transcription complex.
    Lin MH; Apolloni A; Cutillas V; Sivakumaran H; Martin S; Li D; Wei T; Wang R; Jin H; Spann K; Harrich D
    J Virol; 2015 May; 89(9):4827-36. PubMed ID: 25673710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nullbasic, a potent anti-HIV tat mutant, induces CRM1-dependent disruption of HIV rev trafficking.
    Lin MH; Sivakumaran H; Apolloni A; Wei T; Jans DA; Harrich D
    PLoS One; 2012; 7(12):e51466. PubMed ID: 23251541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DDX3 RNA helicase is required for HIV-1 Tat function.
    Yasuda-Inoue M; Kuroki M; Ariumi Y
    Biochem Biophys Res Commun; 2013 Nov; 441(3):607-11. PubMed ID: 24183723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mathematical model of the Tat-Rev regulation of HIV-1 replication in an activated cell predicts the existence of oscillatory dynamics in the synthesis of viral components.
    Likhoshvai VA; Khlebodarova TM; Bazhan SI; Gainova IA; Chereshnev VA; Bocharov GA
    BMC Genomics; 2014; 15 Suppl 12(Suppl 12):S1. PubMed ID: 25564443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-tat Hutat2:Fc mediated protection against tat-induced neurotoxicity and HIV-1 replication in human monocyte-derived macrophages.
    Kang W; Marasco WA; Tong HI; Byron MM; Wu C; Shi Y; Sun S; Sun Y; Lu Y
    J Neuroinflammation; 2014 Nov; 11():195. PubMed ID: 25416164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A lentiviral vector that activates latent human immunodeficiency virus-1 proviruses by the overexpression of tat and that kills the infected cells.
    Macías D; Oya R; Saniger L; Martín F; Luque F
    Hum Gene Ther; 2009 Nov; 20(11):1259-68. PubMed ID: 19604078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective lentiviral vectors are efficiently trafficked by HIV-1 and inhibit its replication.
    Klimatcheva E; Planelles V; Day SL; Fulreader F; Renda MJ; Rosenblatt J
    Mol Ther; 2001 Jun; 3(6):928-39. PubMed ID: 11407907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A DEAD box protein facilitates HIV-1 replication as a cellular co-factor of Rev.
    Fang J; Kubota S; Yang B; Zhou N; Zhang H; Godbout R; Pomerantz RJ
    Virology; 2004 Dec; 330(2):471-80. PubMed ID: 15567440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent inhibition of HIV-1 replication by a Tat mutant.
    Meredith LW; Sivakumaran H; Major L; Suhrbier A; Harrich D
    PLoS One; 2009 Nov; 4(11):e7769. PubMed ID: 19901984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of simian/human immunodeficiency virus replication in CD4+ T cells derived from lentiviral-transduced CD34+ hematopoietic cells.
    Braun SE; Wong FE; Connole M; Qiu G; Lee L; Gillis J; Lu X; Humeau L; Slepushkin V; Binder GK; Dropulic B; Johnson RP
    Mol Ther; 2005 Dec; 12(6):1157-67. PubMed ID: 16168713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by HIV-1-based lentivirus vectors expressing transdominant Rev.
    Mautino MR; Keiser N; Morgan RA
    J Virol; 2001 Apr; 75(8):3590-9. PubMed ID: 11264348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DDX1 is an RNA-dependent ATPase involved in HIV-1 Rev function and virus replication.
    Edgcomb SP; Carmel AB; Naji S; Ambrus-Aikelin G; Reyes JR; Saphire AC; Gerace L; Williamson JR
    J Mol Biol; 2012 Jan; 415(1):61-74. PubMed ID: 22051512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct DDX DEAD-box RNA helicases cooperate to modulate the HIV-1 Rev function.
    Yasuda-Inoue M; Kuroki M; Ariumi Y
    Biochem Biophys Res Commun; 2013 May; 434(4):803-8. PubMed ID: 23608157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lentiviral vectors for gene therapy of HIV-1 infection.
    Mautino MR
    Curr Gene Ther; 2002 Feb; 2(1):23-43. PubMed ID: 12108972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.